HEADER TRANSCRIPTION 27-SEP-07 2REW TITLE CRYSTAL STRUCTURE OF PPARALPHA LIGAND BINDING DOMAIN WITH BMS-631707 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, RESIDUES 196-468; COMPND 5 SYNONYM: PPAR-ALPHA; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARA, NR1C1, PPAR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS ALPHA HELICAL, ACTIVATOR, DNA-BINDING, METAL-BINDING, NUCLEUS, KEYWDS 2 POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, KEYWDS 3 ZINC, ZINC-FINGER EXPDTA X-RAY DIFFRACTION AUTHOR J.MUCKELBAUER REVDAT 5 03-APR-24 2REW 1 REMARK REVDAT 4 21-FEB-24 2REW 1 REMARK SEQADV HETSYN REVDAT 3 25-OCT-17 2REW 1 REMARK REVDAT 2 24-FEB-09 2REW 1 VERSN REVDAT 1 27-NOV-07 2REW 0 JRNL AUTH W.WANG,P.DEVASTHALE,D.FARRELLY,L.GU,A.PETERS,T.HARRITY, JRNL AUTH 2 M.CAP,C.CHU,L.KUNSELMAN,N.MORGAN,R.PONTICIELLO,R.ZEBO, JRNL AUTH 3 L.ZHANG,K.LOCKE,J.LIPPY,K.O'MALLEY,V.HOSAGRAHARA,L.ZHANG, JRNL AUTH 4 P.KADIYALA,C.Y.CHANG,J.MUCKELBAUER,R.ZAHLER,N.HARIHARAN, JRNL AUTH 5 D.RYONO,P.T.W.CHENG JRNL TITL DISCOVERY OF AZETIDINONE ACIDS AS JRNL TITL 2 CONFORMATIONALLY-CONSTRAINED DUAL (ALPHA/GAMMA) PPAR JRNL TITL 3 ACTIVATORS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.66 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 15043 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 759 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.35 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.41 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1005 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2250 REMARK 3 BIN FREE R VALUE SET COUNT : 51 REMARK 3 BIN FREE R VALUE : 0.3190 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2003 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 63 REMARK 3 SOLVENT ATOMS : 98 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.71 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.74000 REMARK 3 B22 (A**2) : 0.74000 REMARK 3 B33 (A**2) : -1.10000 REMARK 3 B12 (A**2) : 0.37000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.291 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.227 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.158 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.541 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2108 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2851 ; 1.719 ; 2.012 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 252 ; 5.338 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 87 ;33.825 ;24.598 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 376 ;16.926 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ;20.692 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 333 ; 0.103 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1523 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1063 ; 0.211 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1481 ; 0.306 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 118 ; 0.171 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 31 ; 0.216 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 5 ; 0.070 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1313 ; 1.133 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2045 ; 1.846 ; 2.500 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 890 ; 2.005 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 804 ; 3.148 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2REW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-OCT-07. REMARK 100 THE DEPOSITION ID IS D_1000044773. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-SEP-03 REMARK 200 TEMPERATURE (KELVIN) : 100.000000 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : SI-111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28240 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.350 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.43 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : 0.53300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PREVIOUSLY DETERMINED IN HOUSE PPARALPHA LBD REMARK 200 STRUCTURE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.86 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.79 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 32.90500 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 65.81000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 65.81000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 32.90500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 514 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 192 REMARK 465 SER A 193 REMARK 465 HIS A 194 REMARK 465 MET A 195 REMARK 465 GLU A 196 REMARK 465 ASP A 197 REMARK 465 SER A 198 REMARK 465 LYS A 232 REMARK 465 ALA A 233 REMARK 465 SER A 234 REMARK 465 ASN A 235 REMARK 465 ASN A 236 REMARK 465 VAL A 255 REMARK 465 ALA A 256 REMARK 465 LYS A 257 REMARK 465 LEU A 258 REMARK 465 VAL A 259 REMARK 465 ALA A 260 REMARK 465 ASN A 261 REMARK 465 GLY A 262 REMARK 465 ILE A 263 REMARK 465 TYR A 468 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 199 CG CD OE1 OE2 REMARK 470 ASN A 219 OD1 ND2 REMARK 470 LYS A 252 CG CD CE NZ REMARK 470 ASN A 265 CG OD1 ND2 REMARK 470 LYS A 266 CD CE NZ REMARK 470 ASP A 418 CG OD1 OD2 REMARK 470 GLN A 445 CG CD OE1 NE2 REMARK 470 ASP A 466 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 200 -51.41 167.42 REMARK 500 SER A 230 -112.68 -145.56 REMARK 500 ASP A 301 157.17 -33.27 REMARK 500 CYS A 384 42.28 -95.16 REMARK 500 ASN A 393 78.94 -111.58 REMARK 500 ASP A 453 7.72 -67.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 CPQ A 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CPQ A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE REW A 469 DBREF 2REW A 196 468 UNP Q07869 PPARA_HUMAN 196 468 SEQADV 2REW GLY A 192 UNP Q07869 EXPRESSION TAG SEQADV 2REW SER A 193 UNP Q07869 EXPRESSION TAG SEQADV 2REW HIS A 194 UNP Q07869 EXPRESSION TAG SEQADV 2REW MET A 195 UNP Q07869 EXPRESSION TAG SEQRES 1 A 277 GLY SER HIS MET GLU ASP SER GLU THR ALA ASP LEU LYS SEQRES 2 A 277 SER LEU ALA LYS ARG ILE TYR GLU ALA TYR LEU LYS ASN SEQRES 3 A 277 PHE ASN MET ASN LYS VAL LYS ALA ARG VAL ILE LEU SER SEQRES 4 A 277 GLY LYS ALA SER ASN ASN PRO PRO PHE VAL ILE HIS ASP SEQRES 5 A 277 MET GLU THR LEU CYS MET ALA GLU LYS THR LEU VAL ALA SEQRES 6 A 277 LYS LEU VAL ALA ASN GLY ILE GLN ASN LYS GLU ALA GLU SEQRES 7 A 277 VAL ARG ILE PHE HIS CYS CYS GLN CYS THR SER VAL GLU SEQRES 8 A 277 THR VAL THR GLU LEU THR GLU PHE ALA LYS ALA ILE PRO SEQRES 9 A 277 GLY PHE ALA ASN LEU ASP LEU ASN ASP GLN VAL THR LEU SEQRES 10 A 277 LEU LYS TYR GLY VAL TYR GLU ALA ILE PHE ALA MET LEU SEQRES 11 A 277 SER SER VAL MET ASN LYS ASP GLY MET LEU VAL ALA TYR SEQRES 12 A 277 GLY ASN GLY PHE ILE THR ARG GLU PHE LEU LYS SER LEU SEQRES 13 A 277 ARG LYS PRO PHE CYS ASP ILE MET GLU PRO LYS PHE ASP SEQRES 14 A 277 PHE ALA MET LYS PHE ASN ALA LEU GLU LEU ASP ASP SER SEQRES 15 A 277 ASP ILE SER LEU PHE VAL ALA ALA ILE ILE CYS CYS GLY SEQRES 16 A 277 ASP ARG PRO GLY LEU LEU ASN VAL GLY HIS ILE GLU LYS SEQRES 17 A 277 MET GLN GLU GLY ILE VAL HIS VAL LEU ARG LEU HIS LEU SEQRES 18 A 277 GLN SER ASN HIS PRO ASP ASP ILE PHE LEU PHE PRO LYS SEQRES 19 A 277 LEU LEU GLN LYS MET ALA ASP LEU ARG GLN LEU VAL THR SEQRES 20 A 277 GLU HIS ALA GLN LEU VAL GLN ILE ILE LYS LYS THR GLU SEQRES 21 A 277 SER ASP ALA ALA LEU HIS PRO LEU LEU GLN GLU ILE TYR SEQRES 22 A 277 ARG ASP MET TYR HET CPQ A 1 25 HET REW A 469 38 HETNAM CPQ N,N-BIS(3-D-GLUCONAMIDOPROPYL)DEOXYCHOLAMIDE HETNAM REW (2S,3S)-1-(4-METHOXYPHENYL)-3-(3-(2-(5-METHYL-2- HETNAM 2 REW PHENYLOXAZOL-4-YL)ETHOXY)BENZYL)-4-OXOAZETIDINE-2- HETNAM 3 REW CARBOXYLIC ACID HETSYN CPQ DEOXY-BIGCHAP HETSYN REW 4-[2-(3-{[(2S,3S)-2-CARBOXY-1-(4-METHOXYPHENYL)-4- HETSYN 2 REW OXOAZETIDIN-3-YL]METHYL}PHENOXY)ETHYL]-5-METHYL-2- HETSYN 3 REW PHENYL-1,3-OXAZOL-3 -IUM FORMUL 2 CPQ C42 H75 N3 O15 FORMUL 3 REW C30 H28 N2 O6 FORMUL 4 HOH *98(H2 O) HELIX 1 1 THR A 200 PHE A 218 1 19 HELIX 2 2 ASN A 221 LEU A 229 1 9 HELIX 3 3 ASP A 243 LEU A 254 1 12 HELIX 4 4 GLU A 267 LYS A 292 1 26 HELIX 5 5 GLY A 296 LEU A 300 5 5 HELIX 6 6 ASP A 301 SER A 322 1 22 HELIX 7 7 ALA A 333 GLY A 335 5 3 HELIX 8 8 ARG A 341 SER A 346 1 6 HELIX 9 9 PRO A 350 ILE A 354 5 5 HELIX 10 10 MET A 355 ALA A 367 1 13 HELIX 11 11 ASP A 371 CYS A 384 1 14 HELIX 12 12 ASN A 393 HIS A 416 1 24 HELIX 13 13 PHE A 421 GLU A 451 1 31 HELIX 14 14 HIS A 457 ASP A 466 1 10 SHEET 1 A 4 PHE A 239 ILE A 241 0 SHEET 2 A 4 GLY A 337 THR A 340 1 O PHE A 338 N ILE A 241 SHEET 3 A 4 GLY A 329 VAL A 332 -1 N MET A 330 O ILE A 339 SHEET 4 A 4 MET A 325 ASN A 326 -1 N ASN A 326 O GLY A 329 CISPEP 1 LYS A 349 PRO A 350 0 1.13 SITE 1 AC1 8 LYS A 204 ALA A 207 LYS A 208 ARG A 348 SITE 2 AC1 8 SER A 373 LEU A 410 HIS A 411 GLU A 451 SITE 1 AC2 15 PHE A 273 CYS A 275 CYS A 276 GLN A 277 SITE 2 AC2 15 SER A 280 TYR A 314 MET A 330 VAL A 332 SITE 3 AC2 15 ILE A 354 HIS A 440 ILE A 447 LEU A 456 SITE 4 AC2 15 LEU A 460 TYR A 464 HOH A 527 CRYST1 78.264 78.264 98.715 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012777 0.007377 0.000000 0.00000 SCALE2 0.000000 0.014754 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010130 0.00000